Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?

Backgrounds: Inhaled corticosteroids (ICS)/inhaled long-acting beta(2)-agonists (LABA) combination drugs are widely used for the long-term management of chronic obstructive pulmonary disease (COPD). However, COPD is a heterogeneous condition and treatment with ICS is associated with a higher risk of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Akamatsu, Keiichiro, Matsunaga, Kazuto, Sugiura, Hisatoshi, Koarai, Akira, Hirano, Tsunahiko, Minakata, Yoshiaki, Ichinose, Masakazu
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Research Foundation 2011
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3140651/
https://ncbi.nlm.nih.gov/pubmed/21811461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2011.00036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados